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Background: The transcription factor nuclear factor interleukin 6 (NF-IL6) is known to be activated by
various inflammatory stimuli in the brain. Interestingly, we recently detected NF-IL6-activation within the
hypothalamus-pituitary-adrenal (HPA)-axis of rats after systemic lipopolysaccharide (LPS)-injection. Thus, the aim
of the present study was to investigate whether NF-IL6 is activated during either, inflammatory, or psychological
stress in the rat brain.
Methods: Rats were challenged with either the inflammatory stimulus LPS (100 μg/kg, i.p.) or exposed to a
novel environment. Core body temperature (Tb) and motor activity were monitored using telemetry, animals were
killed at different time points, brains and blood removed, and primary cell cultures of the anterior pituitary lobe (AL)
were investigated. Analyses were performed using immunohistochemistry, RT-PCR, and cytokine-specific bioassays.
Results: Stress stimulation by a novel environment increased NF-IL6-immunoreactivity (IR) in the pituitary’s perivascular
macrophages and hypothalamic paraventricular cells and a rise in Tb lasting approximately 2 h. LPS stimulation lead
to NF-IL6-IR in several additional cell types including ACTH-IR-positive corticotrope cells in vivo and in vitro. Two other
proinflammatory transcription factors, namely signal transducer and activator of transcription (STAT)3 and NFκB, were
significantly activated and partially colocalized with NF-IL6-IR in cells of the AL only after LPS-stimulation, but not following
psychological stress. In vitro NF-IL6-activation was associated with induction and secretion of TNFα in folliculostellate cells,
which could be antagonized by the JAK-STAT-inhibitor AG490.
Conclusions: We revealed, for the first time, that NF-IL6 activation occurs not only during inflammatory LPS stimulation,
but also during psychological stress, that is, a novel environment. Both stressors were associated with time-dependent
activation of NF-IL6 in different cell types of the brain and the pituitary. Moreover, while NF-IL6-IR was partially linked to
STAT3 and NFκB activation, TNFα production, and ACTH-IR after LPS stimulation; this was not the case after
exposure to a novel environment, suggesting distinct underlying signaling pathways. Overall, NF-IL6 can be
used as a broad activation marker in the brain and might be of interest for therapeutic approaches not only
during inflammatory but also psychological stress.
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Inflammatory transcription factors are commonly used as
important brain cell activation markers during infection
and inflammation to investigate immune-to-brain com-
munication [1-7] and represent promising targets for
therapeutic approaches during infectious and inflam-
matory insults [8-11]. However, information about the
physiological role of these transcription factors for the
brain during inflammatory and psychological stress is
limited. As such, previous studies revealed important
implications for pivotal inflammatory transcription factors
including nuclear factor (NF)κB and signal transducer
and activator of transcription (STAT)3 in fever inducing
pathways [8,10]. In concert with endogenous pyrogens,
belonging largely to the cytokine family, exogenous
pathogen-associated molecular patterns derived from
viruses and bacteria [2,3,12-14] lead to a characteristic
transcription factor-mediated activation pattern in the
brain [5,6,15], and brain inflammation. Among others,
this response is linked to the induction of prostaglandin-
dependent fever through several autonomic pathways,
activating effector organs [16,17].
Recently, we observed that another inflammatory
transcription factor, namely NF-interleukin (IL)6, was
induced in brain structures implicated in the febrile
response but also in HPA (hypothalamic-pituitary-adrenal)-
axis activation including the median eminence (ME)
and the pituitary, in a time-dependent manner. We hy-
pothesized that it may play a role in the manifestation
or even termination of fever as well as HPA-axis activity
and brain inflammation [1]. This response was accom-
panied by the hypothalamic expression of important brain
inflammatory target genes including the rate limiting
enzymes in prostaglandin synthesis, for example, cyclo-
oxygenase 2 and microsomal prostaglandin synthase.
In addition to inflammatory stimuli, such as LPS
[1,18-20] or viral infections [2,21], brain NF-IL6-expression
and activation/nuclear translocation were previously
found to be increased in neurons during dehydration
[22], in astrocytes, microglia, and neurons after kainic
acid-trauma [23], via potassium chloride-induced activity
of neurons [24], as neuronal response to axonal injury
[25] or by neurotransmitter-induced activation of astrocytes
[26]. Recently, we have also shown that brain stab-trauma
increases nuclear NF-IL6-IR in the cortex [8]. Interestingly,
NF-IL6 has also been implicated in excitotoxic brain
injury [23], hypoxia [27], microglia-mediated neurotoxic
effects [28], and memory consolidation [29] suggesting
a crucial role for this inflammatory transcription factor
in the brain, and specifically in brain inflammation.
Whether activation of inflammatory transcription factors
also occurs during psychological stress has been previously
investigated for STAT3 and NFκB [30,31] but remains
unknown for NF-IL6.Here, we analyzed, for the first time, the precise spatio-
temporal activation of the pivotal inflammatory tran-
scription factor NF-IL6 during exposure to a psychological
stressor, that is, a novel environment, in comparison to
the inflammatory stimulus lipopolysaccharide (LPS). This
study revealed a distinct activation pattern in different
cell types, such that only perivascular macrophages were
activated by both stimuli, but endothelial cells and cor-
ticotropes were exclusively activated by LPS stimulation.
Moreover, using a primary cell culture of the anterior
pituitary lobe we showed that LPS-induced NF-IL6 and
STAT3 activation might be involved in TNFα expression
by folliculostellate cells. Overall, our data illustrate the
pleiotropic role of NF-IL6 in response to different types of
stressors. This has important implications for therapeutic
strategies, while NF-IL6-immunohistochemistry will also
serve as a useful activation marker for future studies
investigating inflammatory processes in the brain.
Methods
Animals
Male Wistar rats (rattus norvegicus spec.) with a body
weight (BW) of 200 ± 50 g or 250 ± 50 g (cell cultures)
were used for all experiments. The rats originated from
an in-house breeding colony with parental animals
obtained from Charles River WIGA (Sulzfeld, Germany).
Animal care, breeding, and experimental procedures
were conducted according to the guidelines approved
by the local Ethics committee (ethics approval number
GI 18/2 - 51/2008).
Animals were individually housed for the duration of
the experiment in a climate chamber that was controlled
for temperature and humidity (Weiss Umwelttechnik
GmbH, Typ 10'US/+5 - +40 DU, Germany) at an ambient
temperature of 25°C and 50% humidity on an 12:12 h
light–dark cycle (lights off at 19:00). Animals had constant
access to water and powdered standard lab chow (ssniff
Spezialdiäten GmbH Soest, Germany) and were implanted
with intra-abdominal radio transmitters for measurement
of core body temperature (Tb) and motor activity suitable
for rats (T-4000 E-Mitter®/ER-4000 Receiver; Respironics
Inc-MiniMitter, Bend, OR, USA). Implantation of transmit-
ters was performed about 8 days before the experiment as
previously reported [1], using a cocktail of ketamine hydro-
chloride (50 mg/kg, Pharmacia Upjohn), medetomidine
(5 mg/kg, Pfizer; Albrecht), and acepromazine, (0.5 mg/kg)
as anesthetic (i.p.). An automatic data acquisition system
was used (VitalView, Respironics Inc-MiniMitter, Bend,
OR, USA). Rats were handled extensively for at least
3 days prior to the experiment for habituation.
Treatment and experimental protocols
Rats were intraperitoneally (i.p.) injected with LPS
(100 μg/kg or 1 mg/kg BW; derived from Escherichia
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Germany) diluted in sterile pyrogen-free 0.9% PBS
(Dulbecco’s Phosphate Buffered Saline, PAA, D-Cölbe)
at a total injection volume of 1 mL per animal. Control
animals received the equivalent volume of PBS (0.1 M,
pH 7.4). All injections were performed between 09:00
and 10:00. At different time points (2, 4, 8, 10, and 24 h
p.i.) animals were euthanized by terminal anesthesia
with pentobarbital (i.p.; approximately 100 mg/kg, Merial
GmbH, Hallbergmoos, Germany) and transcardially
perfused with ice-cold 0.9% saline.
For the novel environment-stress experiment, rats were
placed into an empty cage (without any food, water, or
bedding) or stayed in their original environment as a
control as previously described [32]. At different time
points (30 (n = 3), 60 (n = 6), 90 (n = 3), 120 (n = 3), 240
(n = 6) min after stress exposure or controls after 60 (n = 6)
and 240 (n = 6) min), rats were euthanized by terminal
anesthesia and perfusion. Blood samples were collected
with a sterile heparinized syringe via cardiac puncture
under anesthesia. These experiments were performed
between 10:00 and 14:00.
After perfusion of all animals, pituitaries and brains
were quickly removed, frozen separately in powdered
dry ice, and stored at −55°C until analysis.
Tissue processing
Coronal 20 μm brain and pituitary sections were cut on
a cryostat (model HM 500, Microm, Walldorf, Germany)
encompassing several hypothalamic brain structures
including the subfornical organ (SFO), the hypothalamic
paraventricular nucleus (PVN), the median eminence
(ME), and the pituitary (anterior lobe (AL), intermediate
lobe (IL), posterior lobe (PL)) using the stereotactic rat
brain atlas of Paxinos and Watson (1998) as reference [33].
The sections were thaw-mounted on poly-L-lysine-coated
glass slides and stored at −55°C until processing.
Immunohistochemistry
Frozen brain sections were air-dried for 7 min at room
temperature (RT), immersion-fixed in 2% paraformalde-
hyde (Merck, Darmstadt, Germany), diluted in PBS for
10 min, and washed three times in PBS. Thereafter, the
sections were incubated for 1 h with a blocking solution,
consisting of PBS, containing 10% normal donkey serum
(NDS; Biozol, Eching, Germany) and 0.1% triton X-100
(no triton X-100 for goat NF-IL6) at RT. Double IHC was
performed for analyses of NF-IL6 immunoreactivity in
endothelial cells, astrocytes, activated microglia, perivascu-
lar macrophages, and neurons. The primary antibodies
(NF-IL6 or TNFα) were mixed with the respective anti-
body to detect specific cell marker proteins (dilutions in
Table 1) and sections were incubated for 20 to 22 h at 4°C.
After another three PBS washes, NF-IL6 was visualizedwith Cy3-conjugated anti-goat or anti-rabbit IgG (cat.
705-165-147 and 711-165-152, respectively; Jackson Im-
munoResearch, West Grove, PA, USA). Cell-type markers
were detected with Alexa-488-conjugated anti-rabbit,
anti-mouse, anti-sheep, or anti-goat IgG (cat. A11055,
A21202, A11015, and A11055, respectively; MoBiTec
GmbH, Goettingen, Germany) as secondary antibodies
(1:500 dilution each). Subsequently, sections were incu-
bated for 10 min with 4.6-diamidino-2-phenylindole (DAPI,
1:1,000 dilution in PBS) to stain cell nuclei (Mobitec GmbH,
Göttingen, Germany), visualize surrounding tissue, and
also to demonstrate nuclear localization of NF-IL6 IR.
Finally, all sections were dipped in a glycerol/PBS solution
(Citifluor LTD, London, UK), cover slipped (glass cover
slips), and stored (at 4°C) until microscopic analysis. All
primary antibodies have been used previously and proved
to show specific signals [1,34].
Microscopical analysis
A light/fluorescent Olympus BX50 microscope (Olympus
Optical, Hamburg, Germany) was used with a black
and white Spot Insight camera (Diagnostic Instruments,
Visitron Systems, Puchheim, Germany) to acquire images.
Digital rat brain maps were arranged for overviews by the
adjustment of corresponding rat brain levels taken from
the digital rat brain atlas of Paxinos and Watson (1998).
Microphotographs for each set of experiment were taken
in series for the relevant time points of stimulated and
control sections at the same time using the same exposure
time (MetaMorph 5.05 software). Image editing software
was applied to combine the individual images into the
RGB color figure plates (MetaMorph 5.05), to adjust
brightness and contrast for better representation and to
store the images as TIFF files (Adobe Photoshop 5.05).
Semi-quantitative analysis of nuclear NF-IL6
immunoreactivity
Relative values of nuclear NF-IL6 immunoreactivity are
presented as estimates for the density of their labeling.
Three (PVN, pituitary), one to three (SFO), or two to four
(LPS stimulation, pituitary) sections per animal for three
to six animals per group were analyzed (Tables 2 and 3).
Evaluation was directly performed for each set of
experiment at the same time. A five-point scale was
used to rate the data as means (2 to 4 sections) of the
means (3 to 6 animals): +++ (5), high density of nuclear
signals; ++ (4), moderate density; + (3), low density; ±
(2), single nuclear signals in some cases; and - (1) no
nuclear signals.
Primary cell culture of the anterior lobe of the pituitary
For each preparation two to three animals were quickly
decapitated with a guillotine and the heads were immersed
(<20 s) in ice-cold 0.1 M phosphate-buffered saline (PBS;
Table 1 Dilutions for the primary antibodies used for immunohistochemistry or immunocytochemistry
Antigen Species, type Dilution Catalog number, manufacturer
NF-IL6 Goat polyclonal IgG 1:250 cat. sc-150-G; Santa Cruz Biotechnology, Santa Cruz, CA, USA
NF-IL6 Rabbit polyclonal IgG 1:9000 cat. sc-150; Santa Cruz Biotechnology, Santa Cruz, CA, USA
STAT3 Rabbit polyclonal IgG 1:8000 cat. sc-21876; Santa Cruz Biotechnology, Santa Cruz, CA, USA
NFκB Goat polyclonal IgG 1:500 cat. sc-372; Santa Cruz Biotechnology, Santa Cruz, CA, USA
VWF Sheep polyclonal IgG 1:3000 cat. SARTW-IG; Affinity Biologicals, Ancaster, Canada
GFAP Mouse monoclonal IgG 1:2000 cat. MAB3402; Millipore, Billerica, MA, USA
CD68 (ED1) Mouse monoclonal IgG 1:1000 cat. MCA341R; AbD Serotec, Oxford, United Kingdom
CD163 (ED2) Mouse monoclonal IgG 1:500 cat. MCA342R; AbD Serotec, Oxford, United Kingdom
NOS1 Rabbit polyclonal IgG 1:500 cat. sc-648; Santa Cruz Biotechnology, Santa Cruz, CA, USA
ACTH (1–24) Rabbit polyclonal IgG 1:2000 Gift from Dr. Blähser, Institute of Anatomy and Cytobiology, JLU Giessen, Germany (Blähser, 1988)
Anti- S100 Rabbit polyclonal IgG 1:250 cat. S2644 Sigma-Aldrich, Munich, Germany
TNFα Goat polyclonal IgG 1:2000 cat. AF-510-NA R&D Systems, MN, USA
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pituitary was immediately removed from the skull under
low-germ/almost sterile conditions and placed into an
ice-cold Petri dish with oxygenated Earle’s Balanced
Salt Solution (EBSS; Invitrogen, Darmstadt, Germany).
The anterior lobe of the pituitary was removed and
placed into a Petri dish filled with ice-cold, oxygenated
Hanks Balanced Salt Solution (HBSS) without Ca2+ and
Mg2+ (Biochrom, Berlin, Germany), but supplemented
with 20 mM HEPES (Sigma-Aldrich), pH 7.4. Pituitary
fragments were then treated with 2 mg/mL dispase-1
(Roche Diagnostics, Mannheim, Germany) in oxygenated
HBSS with 20 mM HEPES, pH 7.4 (90 min at 37.0°C).
After, the pituitary fragments were washed once with
HBSS containing 1.0 mM EDTA (Sigma-Aldrich) to
inactivate the enzyme, then washed three times with
complete medium, consisting of Dulbecco’s Modified
Eagle Medium (DMEM; Invitrogen, Darmstadt, Germany)
supplemented with 10.0% FCS (PAA Laboratories GmbH,
Coelbe, Germany), penicillin (100 U/mL), streptomycin
(0.1 mg/mL), and 4 mM L-glutamine (Biochrom AG,
Berlin, Germany). Finally, tissue was mechanically
dissociated in 2.0 mL complete medium by repeated
trituration with a 1 mL Eppendorf pipette tip. After cell
number determination, cells were diluted to approximatelyTable 2 Semi-quantitative analyses of nuclear NF-IL6 immuno
Brain
structure
Stress
30 60 90
SFO ++ (3.7) + (2.7) ++ (3.7)
PVN ± (2.3) + (3.4) ++ (4.2)
Pituitary + (3.3) ++ (4.3) +++ (5.0)
Semi-quantitative analysis of the amount of nuclear NF-IL6 signals in the subfornica
anterior lobe of the pituitary gland (pituitary) of rats 30, 60, 90, 120, and 240 min af
scale was used to rate the data: + + + (5), high density of nuclear signals; + + (4), m
signals in some cases; - (1), no nuclear signals.250,000 cells per mL and plated onto prewarmed, poly-
L-lysine (0.1 mg/mL; Biochrom AG, Berlin, Germany)-
coated glass coverslips (MAGV GmbH, Rabenau, Germany)
forming the bottom of a reusable Flexiperm-micro-12
well (6 mm diameter; Greiner Bio-One GmbH, Solingen,
Germany) to ensure sufficient cell density despite limited
absolute cell number. Cells were cultured in a humidified
atmosphere of 5% CO2 and 95% air at 37.0°C. The
medium was exchanged the next day to remove cellular
debris. Two days later, the culture medium was exchanged
with serum-free culture medium to prevent potentially
stimulatory effects by its components and experiments
were performed the next day. Cell culture conditions were
chosen according to in-house procedures for primary
neuro-glial cell cultures of the circumventricular organs
[35] and adjusted to protocols for primary pituitary cell
cultures, previously utilized by others [36-38]. For each
experiment, relative cell density was controlled after im-
munohistochemical staining (5 predefined areas counted;
mean of approximately 500 cells).
Treatment protocols
Cells were stimulated with LPS (100 μg/mL) or PBS and
incubated for 6 h. According to a preliminary time course
experiment (data not shown) and results from otherreactivity after novel environment stress (stress)
Time (min)
Control
120 240 60 240
+ (3.0) + (3.3) + (3.0) ± (2.4)
++ (4.3) ± (2.2) ± (2.2) ± (2.0)
+ (2.7) + (2.6) + (3.0) ± (2.3)
l organ (SFO), in the hypothalamic paraventricular nucleus (PVN), and in the
ter stress or 30 and 240 min after a control situation (undisturbed). A five-point
oderate density of nuclear signals; + (3), low density; ± (2), single nuclear
Table 3 Semi-quantitative analysis of LPS-induced nuclear
NF-IL6 immunoreactivity
Time (h) 100 μg/kg LPS 1 mg/kg LPS Control (saline)
Anterior lobe of the pituitary
2 + (3.0)
4 ++ (4.4)
8 +++ (5.0) +++ (4.6) ± (2.0)
10 ++ (4.4)
24 ± (2.0) ± (2.4)
Posterior lobe of the pituitary
2 ± (2.0)
4 ++ (4.1)
8 +++ (4.8) ++ (3.9) ± (2.0)
10 ++ (4.2)
24 ± (2.0) ± (2.2)
Semi-quantitative analysis of the number of nuclear NF-IL6 signals in the
anterior lobe and the posterior lobe of the rat pituitary 2, 4, 8, 10, and 24 h
after injection of 100 ug/kg LPS or 8 and 24 h after the injection of 1 mg/kg LPS
compared to controls (8 h after injection of saline). A five-point scale was used to
rate the data: + + + (5), high density of nuclear signals; + + (4), moderate density of
nuclear signals; + (3), low density; ± (2), single nuclear signals in some cases; - (1),
no nuclear signals.
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to detect TNFα immunreactivity and its release (16 in-
dependent experiments) into the supernatant [39]. In
another set of experiments (3 independent experiments, 2
to 3 wells for each treatment), the JAK-STAT-inhibitor AG
490 (N-Benzyl-3,4-dihydroxybenzylidenecyano-acetamide;
1,5 μg/μL, 5 mM; Enzo Life Sciences International Inc.,
PA, USA) or its diluent (25% Cremophor®EL, Poly-
oxyethylenglyceroltriricinoleat 35, DAC in PBS; into
serum-free medium 1:50; Sigma-Aldrich, Munich, Germany)
were used to preincubate cells 30 min before control or
LPS stimulation. The cells of the anterior lobe of the
pituitary were fixed with 4% freshly prepared parafor-
maldehyde (Merck) in PBS, pH 7.4, for 15 min at RT
and immunocytochemistry was performed as previously
reported [39] using the same antibodies and dilutions
as indicated in Table 1. Supernatants were used for the
determination of TNFα.
Quantification of ACTH-immunoreactive cells
To investigate the effects of LPS treatment and AG490
pretreatment on the number of ACTH-IR cells we
quantified the number of cells in five equal areas using
a conventional ocular counting grid. The selection of
the areas was standardized: in the middle and on the
four outer edges of the cell coated cover slips. First, all
ACTH-positive cells and second the total number of
DAPI-positive cell nuclei were counted. Data were
then calculated as percentage of ACTH-positive cells
out of all cells counted for one experiment. Finally,
the mean percentage of ACTH-positive cells out ofthree independent experiments was calculated and used
for blotting the data and for statistical analyses.
Plasma IL-6 and TNFα measurements
IL-6 and TNFα levels were determined by bioassays.
The IL-6 assay is based on a dose-dependent growth
stimulation by IL-6 on the B9 hybridoma cell line. For
the TNFα-bioassay the cytotoxic effect of TNFα on the
mouse fibrosarcoma cell line WEHI 164 subclone 13
was used as previously reported [2]. The detection limit
of the assay after adjustment for assays dilutions of sam-
ples was 3 international units (IU) for IL-6/mL and
6.0 pg/mL for TNFα. TNFα levels in primary cell culture
supernatants of anterior rat pituitaries were measured
for three independent experiments with 2 to 3 wells for
each treatment and adjusted to the relative cell density in
percentage to LPS and cremophor-stimulated samples.
Data analysis
Abdominal temperatures (at 5-min time intervals) and
cumulative motor activity (cumulative over 15 min periods)
were compared by a two-way repeated measures analysis
of variance (ANOVA) followed by an all pairwise Tukey
multiple comparison post-hoc test (SIGMA Stat®; Systat
Software, Inc., Point Richmond, CA, USA.). Circulating
levels of bioactive IL-6, TNFα, ACTH-positive cells, and
cumulative motor activity over 240 min were compared
by ANOVA followed by Newman-Keuls multiple compari-
son post-hoc test (GraphPad Prism 5 software; San Diego,
CA, USA). P < 0.05 was considered statistically significant.
All data are presented as means ± SEM.
Results
Psychological stress induces hyperthermia,
hyperlocomotion, and increased NF-IL6-IR
Psychological stress induced an increase in Tb from 30
to 120 min (Figure 1A, P < 0.05; mean increase 1.03 ±
0.19 C; stress vs. control) and an increase in locomotor
activity from 30 to 90 min (Figure 1B, P < 0.05), as previ-
ously reported [32]. Plasma IL-6 levels did not increase
over time in the stressed animals (Figure 1C, one way
ANOVA).
These effects were accompanied by increased novel
environment stress-induced nuclear NF-IL6-IR that peaked
between 90 and 120 min in the PVN (Additional file 1E,F)
and between 60 and 90 min in the pituitary (Figure 2D,E)
but was unchanged in other brain structures such as
the SFO (Table 2). NF-IL6-IR appeared to be particularly
strong lining the intermediate lobe and in the anterior
pituitary lobe compared to untreated controls (Figure 2A-G).
A semi-quantitative five-point scale evaluation of two
sections per rat for three or six (for 60 and 240 min)
animals per group confirmed these qualitative observa-
tions (Table 2). In this stress paradigm no NF-IL6-
Figure 1 Tb, motor activity, and plasma IL-6 levels during novel environment stress or control situation in rats. (A) Novel environment
stress (stress) induced a rise in body temperature (Tb). (B) This response was preceded and accompanied by increased motor activity (averaged
cumulative activity over 15 min for each) but (C) no significant rise in plasma interleukin 6 (IL-6)-levels, when compared over time to unstressed
control animals. Dashed black arrows indicate changes in the number of animals; this number of animals reduces with time because of animal
groups being perfused at the indicated time points. n = 3 (30, 90, and 120 min) or 6 (60 and 240 min) for each group of perfusion (stress; control
only for 60 and 240 min). For IL-6 n = 3 or 6 (60 and 240 min) samples were analyzed *P < 0.05.
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D, GFAP), or endothelial cells (Figure 3E,F, VWF) could be
observed. Nonetheless, some NF-IL6-IR positive cells co-
localized with CD163-stained perivascular macrophages in
both the anterior and the posterior pituitary lobe in
stressed (Figure 3H) but not control animals (Figure 3G).
Neither increased activation of STAT3 nor NFκB could be
observed in brains and pituitaries of these animals (data
not shown).LPS induced NF-IL6 IR in pituitary corticotropes and other
cell phenotypes
Systemic LPS stimulation (100 μg/kg) induced increased
NF-IL6-IR in the posterior and anterior pituitary lobe of
rats (Figure 4A-C and E-G) compared to saline injected
controls (Figure 4D). This IR started to increase at 4 h
(Figure 4C) and peaked in its intensity and cell density8 h after the LPS challenge (Figure 4A and E) follow-
ed by a decline after the 10 h (Figure 4F,G) to basal
NF-IL6-IR (Table 3). Interestingly, the magnitude of this
response was not altered, at 8 and 24 h, when a 10× higher
dose of LPS was injected (1 mg/kg, Figure 4H,I). While
the intermediate pituitary lobe did not show any
NF-IL6-IR, particular strong NF-IL6-IR was observed
lining its junctions with both the anterior and the
posterior lobe, as can be observed in the overview and
higher magnifications of Figures 4 and 5. Semi-quantitative
five-point scale evaluation of two to four sections per
rat for three animals per group confirmed these qualitative
observations (Table 3). Figure 5 shows co-localization of
several cell marker proteins with NF-IL6-IR in pituitary
sections of LPS- compared to saline-stimulated animals
8 h after injection. We revealed some ACTH-IR positive
corticotropes (Figure 5Bc) in the anterior and GFAP-IR
positive pituicytes (Figure 5Ca and Da) in the posterior
Figure 2 Novel environment stress (stress) induced a significant increase in nuclear NF-IL6-IR in the pituitary of rats. (A, B) Some
nuclear (DAPI, blue) NF-IL6-IR (red) can be observed in unstimulated control animals. (C-F) After novel environment-stress was introduced, nuclear
NF-IL6-IR peaked (D, E) 60 to 90 min later and (G) declined to control levels at 240 min. GFAP detection (green) was used to better visualize the
posterior pituitary lobe. (H) The schematic overview clearly depicts the substructure of microphotographs, containing all pituitary lobes (anterior
lobe (AL), intermediate lobe (IL), and posterior lobe (PL)). Brightness, contrast, and color balance were adjusted for better representation of the
actual data. The scale bar in A represents 100 μm (applies to A-G).
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cells (von Willebrand factor, VWF-positive cells) showed
NF-IL6-IR-positive nuclei in all parts of the pituitary
(Figure 5Fa-c), whereas nNOS positive cells co-localized
with NF-IL6-IR only in the posterior lobe (Figure 5Ha).
Moreover, CD163 or CD68 positive cells, indicative of the
appearance of perivascular macrophages or activated mac-rophages, respectively, showed nuclear NF-IL6-IR in the
anterior and posterior lobe (Figure 5I-L, a and c for each).
LPS-induced nuclear NF-IL6-IR partly co-localizes with
STAT3 or NFκB-IR in the posterior pituitary lobe
Inflammatory transcription factors are known to interact
and influence transcriptional activity among each other
Figure 3 Novel environment stress (stress) induced nuclear NF-IL6-
IR that co-localizes with CD163-positive perivascular macrophages
in the rat pituitary. NF-IL6-IR (red) was co-localized with specific cell
marker proteins (green) after novel environment-stress (90 min) or in
unstimulated control animals (60 min). (A-H) Stress-induced nuclear
NF-IL6-IR was not co-localized in corticotrope cells (ACTH; A, B), astrocytes
(GFAP; C, D), endothelial cells (VWF; E, F) but in perivascular macrophages
(CD163; H) of the anterior (AL, c) and posterior pituitary lobe (PL, a). Insets
(a-c) show high magnifications of the PL, IL, and AL, respectively. Open
arrows represent either NF-IL6-IR-negative cells of identified phenotype or
some NF-IL6-IR cells of unidentified phenotype (green). White arrow
tips show nuclear NF-IL6-IR in perivascular macrophages. Cell nuclei
were labeled with DAPI (blue). Brightness, contrast, and color balance
were adjusted for better representation of the actual data. The scale
bar in A 100 μm (applies to A-H) and 10 μm for all insets (a-c).
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http://www.jneuroinflammation.com/content/10/1/140[40]. Thus, NF-IL6-IR (Figure 6Aa1-Bb1) was co-localized
with STAT3 (Figure 6A) and NFκB-IR (Figure 6B) in the
pituitary of rats 2 h (NFκB, Figure 6b2-b3) or 4 h (STAT3,
Figure 6a2-a3) after LPS stimulation. As previously re-
ported, nuclear STAT3-IR and NFκB-IR were detected
all over the pituitary gland excluding the intermediate
lobe for NFκB [41,42]. Indeed, NF-IL6-IR co-localized
with both transcription factors in the anterior lobe of
the pituitary. While some cells only showed NF-IL6-IR,
but no STAT3-IR, we did not detect cells that only
showed STAT3-IR without NF-IL6-IR (Figure 6a3). As
for NFκB-IR, co-localization was detected with either
strong or very weak NF-IL6-IR (Figure 6b3). Overall,
some NF-IL6-IR in pituitary cells was clearly detected
in co-localization with STAT3/NFκB but also without
such a co-localization. Novel environment stress did
not significantly induce STAT3 or NFκB-IR in the brain
(data not shown), although this had previously been
reported to be the case after foot shock for STAT3 [31]
or restraint stress for NFκB [30]. This most likely was
due to the much more moderate stress response to a
novel environment in the present study.
LPS-induced NF-IL6-IR in corticotropes is linked to TNFα
induction and release from folliculostellate cells mediated
by JAK-STAT3 activation
LPS-induced NF-IL6-IR in corticotrope cells of the
anterior pituitary lobe was confirmed 6 h after LPS
stimulation of primary pituitary cell cultures (Figure 7a,
representative microphotographs out of 16 independent
experiments) compared to PBS controls (Figure 7A).
This activation was linked to LPS-increased TNFα-IR
in S100-postive folliculostellate cells (Figure 7b) and its
release into the supernatant of the primary cell cultures
(Figure 7E). Pretreatment with the JAK-STAT inhibitor
AG490 (100 μM, 30 min before) drastically reduced
LPS-induced NF-IL6-IR (Figure 7c,d) and TNFα secretion
into the supernatants (Figure 7E), suggesting a role for
this signaling pathway for NF-IL6-activation and TNFα
production and/or release (F3, 24 = 593.3, P < 0.001;
AG490 LPS vs. Crem LPS; Crem PBS vs. Crem LPS;
one-way ANOVA followed by Newman-Keuls multiple
comparison test). Moreover, AG490 treatment in LPS-
stimulated pituitary cells significantly increased the
percentage of ACTH-positive cells compared to solvent
pretreated (Crem LPS) and control cultures (Crem
PBS, AG490 PBS) (Figure 7F; F3, 24 = 9.309; P < 0.001,
AG490 LPS vs. AG490 PBS; P < 0.01, AG490 LPS vs.
Crem PBS, AG490 LPS vs. Crem LPS; one-way ANOVA
followed by Newman-Keuls multiple comparison test).
Discussion
In the current study we revealed for the first time that
the inflammatory transcription factor NF-IL6 is activated
Figure 4 Time course of LPS-induced NF-IL6-IR (red) in the rat
pituitary. (A) An overview shows typical NF-IL6-IR distribution 8 h
after LPS stimulation in the anterior (AL), intermediate (IL), and posterior
pituitary lobe (PL). The dashed square indicates respective localization
of the following microphotographs at higher magnification. (B-G) LPS
stimulation (100 μg/kg i.p.) induced NF-IL6-IR, which peaked 8 h after
injection (E). Some NF-IL6-IR was also observed 8 h after saline injection
(D), which was similar to levels 24 h after LPS stimulation (G). (H, I)
When injecting a 10× higher LPS dose (1 mg/kg i.p.), the amount of
NF-IL6-IR was not further increased at respective time points (8 and
24 h) compared to sections of animals that were stimulated with
100 μg/kg LPS i.p. (D, E). Please note overall strong NF-IL6-IR lining the
IL. Cell nuclei were labeled with DAPI (blue) and pituicytes with GFAP
(green) for better visualization of the surrounding tissue. Brightness,
contrast, and color balance were adjusted for better representation of
the actual data. Scale bar in B represents 100 μm and applies to B-I.
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http://www.jneuroinflammation.com/content/10/1/140not only in the pituitary after in vivo or in vitro stimulation
with the inflammatory stimulus LPS, but also by novel
environment stress in the PVN and the anterior and
posterior pituitary lobe. Moreover, our present results
further broaden the application portfolio for NF-IL6 as
an activation marker, useful for a variety of research
questions ranging from LPS inflammation to psychological
stress models.
Interestingly, spatiotemporal analyses of NF-IL6-IR cel-
lular phenotypes revealed differences between both types
of stressors. On one hand, the time course of NF-IL6-IR
was different (peak at 8 h for LPS vs. approximately
90 min for psychological stress). On the other, while
NF-IL6-IR in perivascular macrophages was detected in
both psychological and immune stress, LPS stimulation
selectively induced NF-IL6 in pituicytes, nNOS-postive
cells, endothelial cells, and corticotropes. In addition,
LPS-induced NF-IL6-IR partially co-localized with NFκB
and STAT3, and was linked to LPS-induced TNFα-IR
in folliculostellate cells of the anterior pituitary lobe
and its release in primary pituitary rat cell cultures. In
contrast, the novel environment-induced NF-IL6 was
not linked to the appearance of other inflammatory
transcription factors.
A hallmark of immune-to-brain communication during
infection, inflammation, and psychological stress is
the concomitant activation of the HPA-axis [43]. First,
corticotropin-releasing hormone (CRH) from parvo-
cellular neurons of the hypothalamic paraventricular
nucleus (PVN) is released at the level of the median
eminence (ME). Second, CRH acts via the portal system
on corticotrope cells in the anterior lobe of the pituitary
that secrete adrenocorticotrope hormone (ACTH). Third,
ACTH induces an increase of corticosteroids in the
circulation derived from the adrenal cortex. Overall,
this response acts as a negative feedback mechanism,
primarily toning down the immune response and limiting
HPA-axis activation [44].
Figure 5 Cellular phenotypes showing lipopolysaccharide (LPS)-induced NF-IL6-IR in the rat pituitary 8 h after stimulation. NF-IL6-IR
(red) was co-localized with specific cell marker proteins (green) after LPS (100 μg/kg i.p.) or PBS stimulation. (A-L) LPS-induced NF-IL6-IR occurred
in corticotrope cells (ACTH, B), pituicytes (GFAP, D), endothelial cells (VWF, F), neuronal nitric oxide synthase-expressing neurons (nNOS, H), perivascular
macrophages (CD163, J), and activated macrophages (CD68, L) in the rat pituitary. PBS-treated controls also exhibited NF-IL6-IR in pituicytes
(C), nNOS-expressing neurons (G), perivascular macrophages (I), and activated macrophages (K) to a certain extent. Please note that representative
microphotographs depict only very few NF-IL6-IR cells in the intermediate lobe (IL), including endothelial cells (b). Insets (a-c) show high magnifications
of the PL, IL, and AL, respectively. Cell nuclei were labeled with DAPI (blue). Brightness, contrast, and color balance were adjusted for better
representation of the actual data. The scale bars in A and C represent 100 μm (applies to A-L) and 10 μm in all insets (applies to a-c). AL,
anterior lobe; IL, intermediate lobe; PL, posterior lobe.
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http://www.jneuroinflammation.com/content/10/1/140Previously, the inflammatory transcription factors STAT3
and NFκB have been implicated in HPA-axis activation
[30,31,41,42,45,46]. Moreover, STAT3, NFκB, and NF-IL6
have been implicated in proopiomelanocortin (POMC,
precursor of ACTH) and CRH-expression [45-48]. Here,
we observed NF-IL6 activation in specific cell types
that, in part, co-localized with ACTH immunoreactivity
(IR) in the pituitary during LPS-induced inflammation,both in vivo and in vitro. This observation supports the
presumption of a contribution of NF-IL6 in POMC/
ACTH expression. However, NF-IL6-IR peaked at a
much later time point after LPS (pituitary, 6 to 8 h) or
novel environment stress (pituitary, 60 to 90 min; PVN,
90 to 120 min) than expected for its potential role in
HPA-axis activation. This stress response starts 15 to
30 min after the inflammatory (LPS, 25 μg/kg) [49] or the
Figure 6 Co-localization of nuclear NF-IL6-IR with NFκB- or STAT3-IR 2 or 4 h after LPS-stimulation. (A, B) The overviews depict the
neuroanatomical structure and distribution pattern of IR in the anterior lobe (AL), the intermediate lobe (IL), and the posterior lobe (PL) of the rat
pituitary. Dashed squares indicate the localization of high magnification (a, b). LPS (100 μg/kg i.p.) induced nuclear (DAPI, blue) NF-IL6-IR (red),
which shows some co-localization with both STAT3- and NFκB-IR (both green) as indicated by open arrows in single channels (a1-2-b1-2) and the
merged overlay (a3-b3) 2 (NFκB) or 4 h (STAT3) after stimulation, respectively. Moreover, nuclear NF-IL6-IR can also be seen without co-localization
(white arrows) and some single nuclear NFκB-IR occurred with only very weak co-localization with NF-IL6-IR (white arrow tips). Brightness, contrast, and
color balance were adjusted for better representation of the actual data. Scale bar in A represents 100 μm (applies to A, B), 10 μm in a1 and applies to
a1-3 and b1-3.
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http://www.jneuroinflammation.com/content/10/1/140psychological stimulus [50] and returns to baseline 480 or
120 min after the respective stimulation. Therefore, if NF-
IL6 is involved in this response, it may contribute to a
late phase of maintained activation in the pituitary or
even its termination. Interestingly, NF-IL6-IR did not
co-localize with ACTH IR after psychological stress,
indicating that the link between NF-IL6 and the stress
axis might not directly involve NF-IL6-mediated ACTHexpression. The precise mechanisms remain to be inves-
tigated in more detail in the future.
With regard to the effects of psychological stress and
the increase in Tb, it remains controversial whether it
represents a true fever (for example, a change in the
thermoregulatory balance point [51] that is accompanied
by an active thermoregulatory response) as opposed to a
passive increase of Tb, termed hyperthermia. In favor of
Figure 7 LPS-induced nuclear NF-IL6-IR is linked to ACTH and
increased TNFα in the rat pituitary. (A, a) Representative
microphotographs show that nuclear (DAPI, blue) NF-IL6-IR (red)
co-localized with some ACTH-positive cells (green) 6 h after LPS
(100 μg/mL, (a) but not PBS treatment (A) in primary cell cultures of
the anterior pituitary lobe. (B, b) Moreover, LPS (100 μg/mL) -induced
TNFα-IR (green) in S100 protein-positive folliculostellate cells (red) 6 h
after stimulation (b), compared to PBS controls (B). (C, c and D, d) In a
different set of experiments, pretreatment (30 min, 100 μM) with the
JAK-STAT inhibitor AG490 reduced LPS (100 μg/mL) -induced NF-IL6-IR
partly in ACTH-IR cells (green) of the anterior pituitary lobe 6 h after
stimulation (d), compared to solvent (cremophor, Cre) -treated controls
(c). Brightness, contrast, and color balance were adjusted for better
representation of the actual data. Scale bars in A (applies to A, a, B and
b) and C (applies to C, c, D and d) represent 10 μm. (E) Relative TNFα
concentration in cell culture supernatants, in PBS- or LPS-stimulated
and cremophor (Cre) or AG490 preincubated primary cell cultures are
presented as percentage of LPS- and Cre-stimulated wells (100%) as
calculated for each experiment. Means of two to three wells of the
means (of each independent experiment, n = 3) were calculated and
revealed a dramatic LPS- and Cre-induced TNFα-increase that was
abolished by AG490 preincubation. (F) Counting of ACTH-IR cells as
percentage of all cells in anterior pituitary cell cultures showed a
significant increase of ACTH-positive cells after AG490 pretreatment in
LPS-stimulated cultures (means of three independent experiments).
AG490 did not show any significant effect on the amount of
ACTH-positive cells in PBS-treated controls. * LPS & Cre vs. LPS &
AG490; *** P <0.001, ** P <0.01.
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http://www.jneuroinflammation.com/content/10/1/140a fever-like process, some studies revealed a prostaglandin
(PG)-dependent rise in Tb [52-54] and increased
thermogenesis by brown adipose tissue [55]. However,
these reports seem to pertain to anticipatory stress
including the open field model (a similar but stronger
stressor compared to the novel environment stress
used in this study) but not others, which were re-
ported to be independent of PG synthesis [56,57]. Our
present results point to some limited contribution of
motor activity to the concomitant increase of Tb in rats
after exposure to a novel environment, which in this sense
might rather represent hyperthermia than fever.
As mentioned before, NF-IL6-IR cell types differed
between the two stress stimuli. We and others have
previously shown LPS-induced NF-IL6-IR in the rat or
mouse brain in vivo [1] and in vitro [18]. For instance,
brain structures with a leaky blood–brain barrier (BBB)
collectively called circumventricular organs (CVOs), such
as the SFO, showed NF-IL6-IR in endothelial cells, as-
trocytes, activated microglia, perivascular macrophages,
and neurons. Here, we again observed LPS-stimulated,
NF-IL6 activation in perivascular macrophages and
endothelial cells, suggesting that circulating mediators
such as LPS and cytokines including IL-6 and TNFα
might contribute to their stimulation in the pituitary.
Since the posterior pituitary belongs to the CVOs and
the anterior pituitary is devoid of a BBB, such a direct
action is probable and supports the longstanding
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http://www.jneuroinflammation.com/content/10/1/140hypothesis concerning immune-to-brain communica-
tion pathways via the humoral pathway [58]. The crucial
role of perivascular macrophages [59-61] and endothe-
lial cells [5,62,63] in this response, both of which were acti-
vated during systemic inflammation, also suggests a
direct influence of circulating inflammatory mediators
on the pituitary and its activity. However, psycho-
logical stress did not induce NF-IL6-IR in endothelial
cells and no significant increase was observed in the
SFO, a brain structure prone to detect circulating me-
diators. In addition, we did not observe a significant
increase in circulating IL-6 levels in these animals, al-
though previous results by others did [64]. In our ex-
periments, this indicates that these IL-6-levels do not
reach a threshold that would elicit a genomic activa-
tion in the brain as previously suggested for STAT3
activation by LPS-induced circulating IL-6 [65]. More-
over, the increase in Tb to an open field exposure was
not altered in IL-6 deficient mice [66] confirming that
NF-IL6 activation in specific cellular phenotypes and
by distinct stress stimuli is dependent on different sig-
naling pathways, for example, a humoral and a neur-
onal one.
In the posterior pituitary lobe we found NF-IL6-IR
pituicytes and cells with strong nNOS-IR with high
amounts of NF-IL6-IR cells lining the intermediate lobe
(IL) after LPS stimulation. Such a strong nNOS-staining
in the posterior lobe and lining the IL has been demon-
strated before and was linked to indirect regulation of
β-endorphin, a POMC-derived peptide, from the inter-
mediate lobe [36]. Thus, NF-IL6 may play a role in this
response; it also has been implicated in production of NO
[67], which is known to modulate HPA-axis activity [68].
Another interesting cellular phenotype in the anterior
pituitary lobe are S100-protein-positive folliculostellate cells,
which also were NF-IL6-IR following LPS administration.
These cells have been previously shown to produce IL-6
after LPS stimulation [43] involving the NFκB pathway
[69]. Gloddek and colleagues (2001) reported that LPS-
induced secretion of ACTH is mediated by IL-6, acting in
the pituitary in a paracrine manner [70]. Here, we revealed
for the first time folliculostellate cells as one of the sources
of TNF production in the pituitary. Although TNFα
expression has been observed throughout the pituitary
[71-73], the cellular phenotype of TNF-expressing cells
has not been determined previously. The shape of TNFα
staining resembled the one that had been shown earlier
for microglia in other primary cell cultures in the so-called
trans-golgi apparatus [39]. Moreover, the release of this
particular cytokine was inhibited by the JAK-STAT
inhibitor AG490, which was accompanied by reduced
NF-IL6-IR. Thus, the JAK-STAT3 and NF-IL6 pathway
seem to be involved in this response. The functional
role, however, of TNFα in the pituitary for HPA-axisactivity remains controversial. Both, inhibitory [74] and
stimulatory effects [75] in the pituitary have been reported
[43] with TNF-binding sites existing in different cellular
phenotypes including folliculostellate cells themselves
[76]. Again, this indicates a potential ambivalent role
for NF-IL6, either stimulating or inhibiting HPA-axis
activity and pituitary/brain function, possibly mediated
via TNFα. Here, we found an increased percentage of
ACTH-positive cells after AG490 pretreatment in LPS-
stimulated cell cultures of the anterior pituitary lobe,
while the LPS-induced increase of TNFα levels in super-
natant was abolished. This observation indicates that
TNFα might, indeed, rather be an inhibitory factor for
ACTH expression in response to LPS stimulation.
Recently, NFκB, which is also activated by TNFα, was
reported to be crucial for the stress response after LPS
and open field stress in vivo [30]. While LPS-induced
NFκB activity increased IL-6-expression in folliculostellate
cells, it inhibited ACTH expression in corticotropes.
Mehet et al. (2012) proposed that this striking difference
in the NFκB response, depending on the implicated
cell phenotypes, represents a regulatory machinery that
enhances CRH-activated HPA-axis activity at early stages.
When CRH reaches high levels, LPS-induced activation in
corticotropes might serve as a limiting inhibitory pathway.
Opposed to this report, in another study, TNF-induced
NFκB activation seemed to directly contribute to POMC
expression in vitro [45]. Collectively, POMC expression
most likely depends on several transcription factors
including NFκB, STAT3, and NF-IL6, since their activity
and function depends on physical interaction with each
other [40,77]. For instance, NF-IL6 may enhance NFκB-
associated signaling [78] and STAT3 enhances NF-IL6
activation [79], knowing that all of them can somehow
contribute to POMC expression as mentioned before.
In this regard, leukemia inhibitory factor (LIF) was shown
to be important for STAT3- and NF-IL6-dependent
POMC expression [47,80]. Indeed, LIF contributes to
LPS-induced ACTH levels in vivo [81]. In the present
study, we found some co-localization of STAT3 with
NF-IL6 and of NFκB with NF-IL6, suggesting that such
interactions might play an important role in the complex
function of HPA-axis activation, although a time-controlled
subsequent activation of the three inflammatory transcrip-
tion factors (first NFκB, then STAT3, followed by NF-IL6)
also seems to take place. However, some inhibitory
functions of NF-IL6 when interacting with STAT3/NFκB
has also been described previously [82,83].
Conclusions
Overall, these present results show, for the first time, an
activation of the pivotal inflammatory transcription factor,
NF-IL6 following a psychological stressor, and reveal new
insights in LPS-induced NF-IL6 activation in the pituitary.
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http://www.jneuroinflammation.com/content/10/1/140NF-IL6 function seems to be, in part, linked to STAT3,
NFκB, and HPA-axis activation. Moreover, we reveal
evidence for distinct pathways in the spatiotemporal
NF-IL6 activation after either psychological or inflam-
matory stress (that is, humoral vs. non-humoral). While
brain perivascular macrophages are activated in response
to both stressors, endothelial cells, pituicytes, CD68
positive cells, and corticotropes show NF-IL6 activation
only after LPS stimulation. The role of NF-IL6/STAT3 in
LPS-induced inflammation seems to involve modulation
of TNFα expression in folliculostellate cells of the pituitary
as shown by inhibition of LPS-induced TNFα levels in
cell culture supernatants by the JAK-STAT/NF-IL6
inhibitor AG490. In addition, this treatment, that is,
TNFα inhibition, was associated with increased num-
bers of ACTH-positive cells. Subsequently, not only
STAT3, but also NF-IL6 activity might potentially be
linked to a modulation of stress-axis activity, but this
remains to be confirmed in future studies. As inflammatory
transcription factors are important brain cell activation
markers and therapeutical targets for a variety of endogen-
ous (glucocorticoids) and exogenous (that is, [9]) anti-
inflammatory/inhibitory strategies, these observations
are of high interest for a broad context of research
areas and questions involving inflammatory as well as
psychological stress models and brain inflammation.Additional file
Additional file 1: Novel environment (stress) -induced significant
increase in NF-IL6-IR in the rat hypothalamic paraventricular nucleus
(PVN). Nuclear (DAPI, blue) NF-IL6-IR (red) was co-localized with the specific
cell marker protein for endothelial cells namely von Willebrand factor (VWF,
green) after LPS (100 μg/kg i.p.) or PBS stimulation. (A-G) LPS stimulation
induced a peak in nuclear NF-IL6-IR at 90 to 120 min (E, F) after stimulation.
This response declined at 240 min (G) to control levels (A, B). Insets (a-g)
represent high magnifications in close vicinity to the third ventricle. Please
note some constitutive NF-IL6-staining in ependymal cells, which is not
significantly enhanced after the stress stimulus. (H) The schematic overview
clearly depicts the substructure of microphotographs, containing medial
parts of the PVN. Brightness, contrast, and color balance were adjusted
for better representation of the actual data. Scale bar in A represents
100 μm (applies to A-G); 3 V, third ventricle.Abbreviations
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